+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Changes in Plasma Corticosterone and Hypothalamic CRF Levels Following Intraventricular Injection or Drug-induced Changes of Brain Biogenic Amines in the Rat

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          In order to study the role of brain biogenicamines in the regulation of ACTH secretion under basal and stress conditions, we examined changes in plasma corticosterone and hypothalamic CRF levels in male and female rats following either the intraventricular injection of biogenic amines or drug-induced changes in brain amine content. Various amounts (from 1 to 250 µg) of norepinephrine (NE), dopamine (DA), serotonin, carbachol and γ-aminobutyric acid (GABA) were injected into the lateral ventricle of the brain of conditioned unanesthetized rats through chronically-implanted cannulae. All the substances except GABA elicited a significant increase in ACTH secretion at the higher doses used. The stimulatory effects of centrally administered amines were partly abolished by prior treatment with reserpine or with reserpine along with Nembutal. Brain amines were depleted by pretreatment with either reserpine or 6-hydroxydopa-mine. In spite of the persistence of marked depletion of hypothalamic NE content, the basal circadian rhythm as well as stress-induced changes in both plasma corticosterone and hypothalamic CRF levels were preserved in almost the normal fashion. In addition, more than two-fold increases of brain amine concentration by pretreatment with a MAO inhibitor affected neither basal circadian rhythm nor a stress-induced increase in the plasma corticosterone. These observations suggest strongly that brain amines are of relatively little importance in the central regulation of ACTH secretion in the rat.

          Related collections

          Author and article information

          S. Karger AG
          20 March 2008
          : 14
          : 3-4
          : 195-211
          Department of Physiology, Hokkaido University School of Medicine, Sapporo
          122259 Neuroendocrinology 1974;14:195–211
          © 1974 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 17


          Comment on this article